Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

NCT00944047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nab-paclitaxel
DRUG: trastuzumab
DRUG: Doxorubicin
DRUG: cyclophosphamide
BIOLOGICAL: Growth Factor Support
PROCEDURE: Surgery

Sponsor

University of Kansas Medical Center

Collaborators

[object Object]